Results 21 to 30 of about 4,685 (255)

Association between remimazolam and postoperative delirium in older adults undergoing elective cardiovascular surgery: a prospective cohort study [PDF]

, 2022
Purpose: Postoperative delirium is one of the most common complications after cardiovascular surgery in older adults. Benzodiazepines are a reported risk factor for delirium; however, there are no studies investigating remimazolam, a novel anesthetic ...
Aoki, Yoshitaka, Doi, Matsuyuki, Imai, Ryo, Kinoshita, Hiroyuki, Kurita, Tadayoshi, Makino, Hiroshi, Nakajima, Mikio, Nakajima, Yoshiki, Suzuki, Yuji   +8 more
core   +2 more sources

Efficacy and safety of remimazolam besilate for sedation in outpatients undergoing impacted third molar extraction: a prospective exploratory study

BMC Oral Health, 2023
Background Dental treatments often cause anxiety, fear, and stress in patients. Intravenous sedation is widely used to alleviate these concerns, and various agents are employed for sedation.
Kana Oue, Aya Oda, Yoshitaka Shimizu, Tamayo Takahashi, Hisanobu Kamio, Utaka Sasaki, Serika Imamura, Eiji Imado, Akari Mukai, Mitsuru Doi, Miyuki Sakuma, Shigehiro Ono, Tomonao Aikawa, Mitsuhiro Yoshida   +13 more
doaj   +1 more source

A comprehensive review of remimazolam for sedation  [PDF]

Health Psychology Research, 2021
Benzodiazepines are one of the most commonly used medications in the field of anesthesia. They offer excellent anxiolytic and amnestic properties ideal for the perioperative period when patient anxiety is understandably heightened. Remimazolam has presented a favorable alternative to some of the common intravenous anesthetic agents used given its fast ...
Nazir Noor, Rhorer Legendre, Alexandra Cloutet, Ahish Chitneni, Giustino Varrassi, Alan D. Kaye   +5 more
openaire   +3 more sources

Remimazolam for anaesthesia or sedation [PDF]

Current Opinion in Anaesthesiology, 2020
Purpose of review Anaesthesia and sedation are ubiquitous in contemporary medical practice. Developments in anaesthetic pharmacology are targeted on reducing physiological disturbance whilst maintaining or improving titrateability, recovery profile and patient experience.
J Robert, Sneyd, Ann E, Rigby-Jones
openaire   +2 more sources

Comparison of hemodynamics during induction of general anesthesia with remimazolam and target-controlled propofol in middle-aged and elderly patients : a single-center, randomized, controlled trial [PDF]

, 2023
Background Remimazolam confers a lower risk of hypotension than propofol. However, no studies have compared the efficacy of remimazolam and propofol administered using target-controlled infusion (TCI).
00622606, 1645, 208068/profile-ja.html, 208070/profile-ja.html, 248936/profile-ja.html, 264524/profile-ja.html, 30263841, 453, 454, 592, 60304/profile-ja.html, 656, 90711862, Kakuta, Nami, Kawanishi, Ryosuke, Kinoshita, Michiko, Sakai, Yoko, Sekiguchi, Ryo, Tanaka, Katsuya, カクタ, ナミ, カワニシ, リョウスケ, キノシタ, ミチコ, サカイ, ヨウコ, セキグチ, リョウ, セキグチ, リョウ, タナカ, カツヤ, 川西, 良典, 木下, 倫子, 田中, 克哉, 角田, 奈美, 酒井, 陽子   +30 more
core   +3 more sources

Remimazolam Has Low Oral Bioavailability and No Potential for Misuse in Drug-Facilitated Sexual Assaults, with or Without Alcohol: Results from Two Randomised Clinical Trials

Drugs in R&D, 2020
Background and Objectives Remimazolam is a new ultra-short-acting benzodiazepine currently being developed for intravenous use in procedural sedation, general anaesthesia, and intensive care unit sedation.
Marija Pesic, Thomas Stöhr, Joachim Ossig, Keith Borkett, Martin Donsbach, Van-Anh Dao, Lynn Webster, Frank Schippers   +7 more
doaj   +1 more source

Total intravenous anesthesia management with simultaneous use of remimazolam and propofol: A case series of three patients

SAGE Open Medical Case Reports, 2023
Remimazolam is an ultra-short-acting benzodiazepine anesthetic agent. Because of pharmacodynamic interactions in the sedation effect between benzodiazepines and propofol, the combination of remimazolam and propofol may allow for a dose reduction of each ...
Yuki Watanabe, Shinju Obara, Satoki Inoue   +2 more
doaj   +1 more source

Efficacy and Recovery of Remimazolam Versus Midazolam in Sedated Colonoscopy: A Multicenter Randomized Controlled Trial in Japan. [PDF]

Dig Endosc
ABSTRACT Objectives Sedation during colonoscopy is becoming increasingly important. Remimazolam, an ultra‐short‐acting benzodiazepine, has a shorter pharmacokinetic half‐life than that of midazolam. This study examined whether remimazolam provides superior sedation during colonoscopy in Japanese patients.
Yamaguchi D, Ichijima R, Ikehara H, Minoda Y, Esaki M, Takamori A, Yoh A, Shirouzu M, Sadashima K, Fujimura Y, Shimamura T, Takedomi H, Akutagawa T, Tsuruoka N, Sakata Y, Wada T, Kusano C, Shimoda R, Esaki M.   +18 more
europepmc   +2 more sources

New Sedatives and Analgesic Drugs for Gastrointestinal Endoscopic Procedures [PDF]

, 2022
Procedural sedation has become increasingly common in endoscopy. Sedatives and analgesics induce anxiolysis and amnesia. In addition, an appropriate level of sedation is necessary for safe procedures including therapeutic endoscopy.
Byung-Wook Kim, Hong Jun Park, Hyun Ho Choi, Hyung Ku Chon, Jae Min Lee, Jee Hyun Lee, Jin Myung Park, Jun Kyu Lee, Jun Yong Bae, Jun-Won Chung, null null, Seung Young Seo, Yehyun Park   +12 more
core   +2 more sources

Remimazolam Anesthesia for MitraClip Implantation in a Patient with Advanced Heart Failure

Case Reports in Anesthesiology, 2021
Remimazolam, a novel and ultrashort-acting benzodiazepine, has been available for general anesthesia in Japan. The administration of remimazolam does not induce injection pain, has been reported to have less cardiovascular depressant effects during ...
Tomoe Satoh, Noriaki Nishihara, Yasuaki Sawashita, Sho Ohno, Naoyuki Hirata, Michiaki Yamakage   +5 more
doaj   +1 more source